UNSPSC 51282414: Carbenicillin indanyl

This classification denotes an extended spectrum penicillin antibiotic with the molecular formula C26H26N2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5V278481KE, chemically known as 1-(5-indanyl)(2s,5r,6r)-n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamate, but more generally known as carbenicillin indanyl, which bears US NIH Compound Identifier 93184.

UNSPSC 51282414 Carbenicillin indanyl is a Commodity code for a specific oral antibiotic pharmaceutical product; however, recent state and local procurement activity tagged to this code does not reflect actual purchases of carbenicillin indanyl itself. Instead, the posting record shows completed and historical solicitations for unrelated pharmaceutical products—doxycycline hyclate and ciprofloxacin hydrochloride tablets under one award, and naloxone with drug deactivation systems under another. The mismatch between the code's nominal scope and the work actually being sourced suggests this code sees little or no relevant current activity in state and local procurement. State and local health agencies, county governments, and special-purpose health districts are the primary issuing bodies for pharmaceutical procurement in this code family, typically using cooperative purchasing vehicles such as MMCAP Infuse or direct IFB processes to source medications and related health supplies.

The geographic spread of recent activity is limited. Illinois Department of Public Health completed a piggyback pharmaceutical award through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for $2,999,999.11 over three years (12 months initial plus two renewal options), although that solicitation addressed doxycycline hyclate and ciprofloxacin, not carbenicillin indanyl. A second posting from Seminole County, Florida, dated June 30, 2026, with a response deadline of July 26, 2026, sought naloxone and drug deactivation systems through IFB—again, unrelated to the carbenicillin indanyl commodity code. The absence of active solicitations specifically for carbenicillin indanyl, combined with the tagging mismatches in the available records, indicates minimal current procurement momentum under this code.